Results 191 to 200 of about 39,387 (293)

Exploring Brain Parenchymal Changes in Acromegaly: Focus on White Matter Hyperintensities

Clinical Endocrinology, EarlyView.
ABSTRACT Introduction Acromegaly is a rare chronic disease caused by excessive secretion of growth hormone. Even with biochemical control, hormonal imbalance may lead to cerebral changes. This study aimed to evaluate the presence of white matter hyperintensities (WMHs) in patients with acromegaly.
Denise Costa, Giada Giuliani, Valentina Martines, Chiara Pellicano, Valeria Mercuri, Vittorio Di Piero, Patrizia Gargiulo, Camilla Virili   +7 more
wiley   +1 more source

Sex differences in outcomes after endovascular therapy with prior antiplatelet use: A study from the EVA-TRISP registry. [PDF]

Eur Stroke J
Noseda R, Rea F, Bianco G, Auer E, Heldner MR, Piechowiak EI, Dobrocky T, Michel P, Wegener S, Baazaoui H, Baumgartner P, Curtze S, Martinez-Majander N, Nybondas M, Zini A, Forlivesi S, Paolucci M, De Marchis GM, Dittrich T, Nederkoorn PJ, Wali N, Katan M, Engelter S, Gensicke H, Trüssel S, Pezzini A, Magoni M, Marto JP, Brás Monteiro M, Leker RR, Jubeh T, Padjen V, Cereda CW.   +32 more
europepmc   +1 more source

Determination of platelet function in patients with cerebral infarction on antiplatelet therapy

, 1993
Tadatoshi Komiya, Manabu Kudo, Takao Urabe, Yoshikuni Mizuno   +3 more
openalex   +2 more sources

Risk of acute pancreatitis with DPP‐4 inhibitors versus SGLT2 inhibitors in medication‐naïve individuals with diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We investigated whether dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use was associated with a higher risk of acute pancreatitis compared with sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in antidiabetic medication‐naïve individuals.
Takashi Tatewaki, Akira Okada, Yuya Kimura, Hideo Yasunaga   +3 more
wiley   +1 more source

Proton pump inhibitors have no effect on short or long term rebleeding or mortality in patients with overt gastrointestinal bleeding. [PDF]

Sci Rep
Mrad J, Zreik AE, Rizk C, Mansour R, Tamim H, El Sheikh WG, Sharara AI, Mourad FH, Daniel F, Soweid A, Shaib YH, El Asmar N, Rockey DC, Barada KA.   +13 more
europepmc   +1 more source

Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival

European Journal of Haematology, EarlyView.
ABSTRACT Background Polycythemia vera (PV) and essential thrombocythemia (ET) are associated with a well‐recognized increased risk of thrombotic events, bleeding, and all‐cause mortality, but the frequency of these outcomes during treatment has rarely been assessed in large cohorts.
Anneli Enblom Larsson, Henrik Renlund, Björn Andréasson, Henrik Holmberg, Maria Liljeholm, Anders Själander   +5 more
wiley   +1 more source

Comparison of the antiplatelet effect of clopidogrel hydrogeno sulfate and clopidogrel besylate in patients with stable coronary artery disease [PDF]

, 2013
M. C. Chamilos, I. Saloustros, GE Kochiadakis, E. S. Skalidis, N. I. Igoumenidis, D. Vougia, I. L. Logkakis, P. Vardas   +7 more
openalex   +1 more source

TGFβ enhances platelet–breast‐cancer‐cell interaction and promotes platelet aggregation

The FEBS Journal, EarlyView.
TGFβ stimulation promotes EMT in MCF7 cells, increasing their ability to bind, activate, and aggregate PLT. This effect involves the upregulation of adhesion molecules Integrin‐αv and Galectin‐3. Inhibiting Integrin‐αv or Galectin‐3, through Cilengitide and GB1103, reduces PLT adhesion to MCF7 and PLT aggregation, suggesting a mechanism linking TGFβ ...
Margherita Genitoni, Lucia Merolle, Agnese Razzoli, Eleonora Maurizi, Gaia Gavioli, Roberto Baricchi, Chiara Marraccini, Davide Schiroli   +7 more
wiley   +1 more source

Bleeding Risk With Combining Antiplatelets and Anticoagulants for Secondary Stroke Prevention: A Propensity Score-Matched Analysis. [PDF]

J Am Heart Assoc
Farrokh S, Nalleballe K, Onteddu S, Suarez JI, Bösel J, Shah VA.   +5 more
europepmc   +1 more source

Carotid Intima‐Media Thickness as a Marker of Subclinical Atherosclerosis in Adolescents With Severe Haemophilia

Haemophilia, EarlyView.
ABSTRACT Background The clinical focus of haemophilia has expanded beyond bleeding outcomes to encompass long‐term comorbidities such as cardiovascular disease (CVD). However, it remains unclear when vascular changes begin in this population. Carotid intima‐media thickness (cIMT), a validated, non‐invasive marker of subclinical atherosclerosis, may ...
Alyson Trillo, Juanita Hunter, Audrey Ofir, Jamie Shoag, Joanna A. Davis, Fernando F. Corrales‐Medina   +5 more
wiley   +1 more source